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We compared a set of surface EMG (sEMG) parameters in several groups of
schizophrenia (SZ, n = 74) patients and healthy controls (n = 11) and coupled them
with the clinical data. sEMG records were quantified with spectral, mutual information (MI)
based and recurrence quantification analysis (RQA) parameters, and with approximate
and sample entropies (ApEn and SampEn). Psychotic deterioration was estimated
with Positive and Negative Syndrome Scale (PANSS) and with the positive subscale
of PANSS. Neuroleptic-induced parkinsonism (NIP) motor symptoms were estimated
with Simpson-Angus Scale (SAS). Dyskinesia was measured with Abnormal Involuntary
Movement Scale (AIMS). We found that there was no difference in values of sEMG
parameters between healthy controls and drug-naïve SZ patients.The most specific
group was formed of SZ patients who were administered both typical and atypical
antipsychotics (AP). Their sEMG parameters were significantly different from those of
SZ patients taking either typical or atypical AP or taking no AP. This may represent a
kind of synergistic effect of these two classes of AP. For the clinical data we found that
PANSS, SAS, and AIMS were not correlated to any of the sEMG parameters. Conclusion:
with nonlinear parameters of sEMG it is possible to reveal NIP in SZ patients, and it may
help to discriminate between different clinical groups of SZ patients. Combined typical
and atypical AP therapy has stronger effect on sEMG than a therapy with AP of only one
class.
Keywords: surface EMG, spectrum, recurrence quantification, mutual information, schizophrenia, antipsychotics,
parkinsonism, motor symptoms
1. Introduction
Schizophrenia (SZ) is one of the most serious and intensively studied neuropsychiatric disorders.
About 1% of population suffers from schizophrenia, regardless of the development level of a
country (Tandon et al., 2008). SZ is characterized by distinct phasic course, with a premorbid, a
prodromal, a psychotic phase, and a phase of remission (Tandon et al., 2009). The overall economic
burden of SZ, for example in the USA, was estimated to be $62.7 billion in 2002 (Wu et al., 2005).
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According to the plausible current hypothesis, SZ symptoms
are associated with increased dopamine production in
mesocortical and mesolimbic pathways and increased density
of D2-receptors (van Os and Kapur, 2009). Dopamine receptors
play an important part in muscle tone regulation (Double and
Crocker, 1995), so it is likely that hyperproduction of dopamine
and increased sensitivity of dopamine receptors in SZ can
affect not only mental, but also the motor processes. Indeed,
patients with SZ exhibit a variety of motor deficits. Among
them are ataxia, extrapyramidal disturbances, pathological
locomotor patterns (Goryunova, 1994), dyskinesia (Puri et al.,
1999), asymmetry of motoneurons excitability (Goode and
Manning, 1988), reduced ability to motor reorganization,
and disrupted neural plasticity (Daskalakis et al., 2008). A
recent study found that such hyperkinetic movements as
writhing or flinging movements of the limbs, fingers or face
indicated those high-risk individuals who would later convert
to psychosis (Mittal and Walker, 2007). Electromyography
(EMG) is believed to be a good instrumental method to ascertain
whether specific dyskinesias (e.g., dystonia) or dyskinesias
of specific body regions are associated with transitioning to
psychosis (Callaway et al., 2014). Earlier, Crayton et al. (1977)
have revealed increased muscle fiber density and number of
single muscle fiber action potentials belonging to the same
motor unit (MU), thus evidencing denervation/reinnervation
process in psychotic patients. Flyckt et al. (2000) have revealed
in SZ patients pathologically increased amplitude of MU action
potentials, which nonetheless did not correlate with muscle
biopsy findings.
Interestingly, in Parkinson’s disease (PD), which is
characterized by the dopamine deficiency in the basal ganglia,
surface EMG (sEMG) contains large portions of clustered
potentials. This causes specific changes in many of sEMG
nonlinear parameters, e.g., decreased entropy and correlation
dimension, and increased percent of determinism. sEMG in
PD in a way is more predictable, less complex, and more
regular (Meigal et al., 2009, 2012). Such pattern of sEMG
may be caused by increased synchronization of motor units
(Fattorini et al., 2005). Also, the nonlinear parameters of
sEMG were shown to be sensitive to the state of muscle pain
(Sung et al., 2007). Psychosis in PD is a frequent condition
affecting as much as 20% of all PD patients (Levin et al., 2015),
while drug-induced parkinsonism (DIP) is seen in one third
of patients exposed to antipsychotic drugs (Blanchet et al.,
2012). Recently, we have demonstrated that most of sEMG
parameters in a group of SZ patients were clearly different
from the control group probably due to DIP (Miroshnichenko
et al., 2014). We believe that coupling of clinical data from SZ
patients with sEMG parameters would be helpful in further
understanding of motor symptoms and sEMG changes in SZ
patients.
Therefore, the aim of the present study was to couple a variety
of sEMG parameters in several clinical groups of SZ patients with
the positive and negative symptoms of SZ with special regard to
the antipsychotic therapy.
2. Materials and Methods
2.1. Patients
We divided all SZ patients (n = 74, 18–58 years) in two groups:
the SZ patients in remission phase (R group) and the patients in
acute psychosis (P group). Also, we divided all SZ patients into
the group of patients who were taking any antipsychotics at the
moment of the study (AP group) and the group of drug-naïve
patients who had never taken antipsychotics (DN). The AP group
was split into the subgroup of patients who were taking typical
antipsychotics (AP/T), the subgroup of patients who were taking
atypical antipsychotics (AP/A), and the subgroup of patients who
were taking both typical and atypical antipsychotics (AP/TA). See
Figure 1 for the diagram of medication-based patients grouping.
SZ phase and medication allowed to distinguish 17 non-empty
groups of patients. See the groups sizes in Table 1. We also used
Table 1 for notation of subgroups of the patients. Each subgroup
was denoted with the names of its row and column in Table 1,
e.g., R-AP/T is the subgroup of patients who were in remission
and taking typical antipsychotics at the moment of study.
The SZ patients in acute psychosis were examined in the
Republican Psychiatric Hospital (settlementMatrosy, Republic of
Karelia, Russian Federation). The SZ patients in remission phase
were examined in the Republican Psychoneurologic Dispensary
(Petrozavodsk, Russian Federation). A variety of symptoms, such
as delusions, hallucinations, psychomotor stupor or agitation,
disorganized behavior, and absence of criticism of pathological
experience were characteristic for all patients under psychotic
condition. Duration of psychosis by examination ranged from
several days to several weeks. Some patients had catatonia,
which mainly appeared in the form of substupor with lethargy,
catalepsy, mutism, and usually it was combined with delusions
or hallucinations. See the medication of the patients in Table 2.
Examination of the antipsychotic-naïve patients as a separate
group (DN) seems to be a relevant model to investigate the
disease per se and to evaluate the action of antipsychotic
medication. The R group was formed of patients without
FIGURE 1 | Patients grouping based on their medication.
Frontiers in Physiology | www.frontiersin.org 2 July 2015 | Volume 6 | Article 197
Meigal et al. Nonlinear sEMG parameters in schizophrenia
TABLE 1 | SZ patients groups sizes (total group size\PANSS is
estimated\SAS and AIMS are estimated).
Group All AP AP/T AP/A AP/TA DN
All 74\58\62 63\49\54 25\20\21 24\19\22 14\10\11 11\9\8
R 13\10\11 13\10\11 7\6\7 3\2\2 3\2\2 0
P 61\48\51 50\39\43 18\14\14 21\17\20 11\8\9 11\9\8
psychotic deterioration for at least 6 months. The patients who
had organic brain lesions beside schizophrenia (traumatic brain
injury, neuroinfections, alcoholism, substance dependencies, and
vascular brain diseases) were excluded from the study, as well
as the patients who were taking psychotropic drugs beside
antipsychotics (antidepressants, mood-stabilizing drugs) or
drug-induced parkinsonism correctors such as trihexyphenidyl.
Taking of benzodiazepine tranquilizers was accepted not less than
15 hours before examination. A control group (Con, n = 11) was
formed of mentally and physically healthy subjects (20–40 years)
who were age- and sex-matched to the DN group.
The study was approved by the ethical committee of
the Republican Psychiatric Hospital (decision #8, 4/11/2012).
Written informed consents were obtained from all patients and
healthy control subjects.
2.2. Methods
Psychotic deterioration of 58 patients (see their groups in
Table 1) was estimated with Positive and Negative Syndrome
Scale (PANSS, Kay et al., 1987), with a separate consideration
of the positive subscale of PANSS (PSS). Drug-induced
parkinsonism (DIP) motor symptoms of 62 patients (see their
groups in Table 1) were estimated with Simpson-Angus Scale
(SAS, Simpson and Angus, 1970). Dyskinesia of 62 patients (the
same as for SAS) was measured with Abnormal Involuntary
Movement Scale (AIMS, Guy, 1976).
sEMG were measured in standing position from m. biceps
brachii with the forearm flexed at 90◦ (parallel to floor) and the
palm opened and directed upwards. Prior to electrode placement,
the skin was carefully cleaned with cotton alcohol swab. A bipolar
plate-mounted electrode with inter-electrode distance of 15 mm
was used. The reference electrode was attached to ipsilateral wrist.
The records were performed with Neuro-MEP-4 (NeuroSoft
Inc., Ivanovo, Russian Federation) at sampling frequency 20 kHz
with 50Hz notch filter enabled. The lower and upper cutoff
frequencies of the filter of the amplifier of the measuring device
were set to 50 and 1000Hz respectively (−3 dB attenuation at
cutoff frequencies, frequency responses are the same as for 1st
order high-pass and 2nd order low-pass Butterworth filters). For
each subject, first record was made without any load, then three
more records were made with 1, 2, and 3 kg loads on the palm.
Each record was 1 s (20001 samples) long. Data processing and
analysis, with the exception of mutual information calculations,
were performed with Matlab software (MathWorks Inc., Natick,
USA). Mutual information was computed using program by
Weeks (1997).
Five measurements from the SZ patients and one
measurement from the Con group appeared to have artifacts in
TABLE 2 | Medication of the patients.
No. Group Medication
1 P-AP/T zuclopenthixol (tf) 30mg DD
2 P-AP/A clozapine (to) 300mg DD
3 P-AP/TA clozapine (to) 300mg DD,
chlorpromazine HCl (to) 300mg DD
4 P-AP/A clozapine (to) 50mg DD
5 P-AP/T zuclopenthixol acetate (im) 100mg AD,
chlorpromazine HCl (pl) 300mg DD
6 P-AP/A quetiapine fumarate (tf) 800mg DD
7 P-AP/A risperidone (tf) 6mg DD
8 P-AP/A quetiapine fumarate (te) 600mg DD,
clozapine (to) 25mg DD
9 P-AP/A risperidone (so) 8mg DD
10 P-AP/A clozapine (to) 500mg DD
11 P-AP/T zuclopenthixol decanoate (im) 200mg 3W,
periciazine (cp) 30mg DD
12 P-AP/T haloperidol (im) 35mg DD,
chlorpromazine HCl (im) 100mg DD
13 P-AP/A risperidone (so) 4mg DD
14 P-AP/A risperidone (td) 8mg DD
15 P-AP/A risperidone (td) 6mg DD
16 P-AP/A risperidone (tf) 3mg DD
17 P-AP/TA risperidone (tf) 10mg DD, clozapine (to)
100 mg DD, haloperidol (to) 20mg DD
18 P-AP/A risperidone (tc) 2mg DD,
clozapine (to) 150mg DD
19 P-AP/TA olanzapine (tc) 15mg DD,
chlorpromazine HCl (im) 50mg DD
20 P-AP/A risperidone (tf) 6mg DD
21 P-AP/T haloperidol (im) 20mg DD,
chlorpromazine HCl (im) 50mg DD
22 P-AP/T haloperidol (im) 15mg DD
23 P-AP/T haloperidol (im) 10mg DD
24 P-AP/A quetiapine fumarate (te) 400mg DD
25 P-AP/T haloperidol (im) 10mg DD
26 P-AP/A risperidone (so) 6mg DD
27 P-AP/T haloperidol (im) 30mg DD,
chlorpromazine HCl (im) 50mg DD
28 P-AP/T haloperidol (im) 20mg DD
29 P-AP/T zuclopenthixol (tf) 40mg DD
30 P-AP/TA haloperidol (to) 45mg DD,
olanzapine (tc) 15mg DD
31 P-AP/A risperidone (ie) 37.5mg 2W
32 P-AP/TA clozapine (to) 175mg DD,
haloperidol (to) 30mg DD
33 P-AP/TA haloperidol (to) 5mg DD,
clozapine (to) 300mg DD
34 R-AP/A sertindole (tc) 4mg DD
35 R-AP/T chlorpromazine HCl (pl) 100mg DD,
haloperidol decanoate (im) 50mg 4W
36 R-AP/TA trifluoperazine (tc) 30mg DD,
clozapine (to) 250mg DD
(Continued)
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TABLE 2 | Continued
No. Group Medication
37 P-AP/T haloperidol (im) 10mg DD
38 P-AP/A risperidone (tf) 8mg DD
39 P-AP/TA haloperidol (im) 30mg DD,
clozapine (to) 300mg DD
40 P-AP/T haloperidol (im) 10mg DD
41 P-AP/TA haloperidol (to) 30mg DD,
clozapine (to) 100mg DD
42 P-AP/TA haloperidol (im) 20mg DD,
clozapine (to) 100mg DD
43 P-AP/T zuclopenthixol acetate (im) 100mg AD
44 P-AP/T haloperidol (im) 5mg DD
45 P-AP/A quetiapine fumarate (te) 600mg DD
46 R-AP/T haloperidol decanoate (im) 50mg 3W
47 P-AP/T haloperidol (im) 10mg DD,
chlorpromazine HCl (im) 50mg DD
48 R-AP/T haloperidol decanoate (im) 50mg 4W
49 R-AP/T trifluoperazine (tc) 5mg DD,
chlorprothixene (tf) 50mg DD
50 R-AP/TA haloperidol decanoate (im) 100mg 2W,
clozapine (to) 100mg DD
51 R-AP/TA haloperidol decanoate (im) 50mg 4W,
clozapine (to) 100mg DD
52 R-AP/T zuclopenthixol decanoate (im) 200mg 4W
53 R-AP/T fluphenazine decanoate (im) 25mg 3W,
levomepromazine (tc) 25mg DD
54 P-AP/A risperidone (so) 3mg DD
55 P-AP/T haloperidol (im) 5mg DD
56 P-AP/TA haloperidol (to) 45mg DD,
clozapine (to) 550mg DD
57 P-AP/T zuclopenthixol acetate (im) 50mg AD
58 P-AP/A risperidone (so) 3mg DD
59 P-AP/TA clozapine (to) 100mg DD,
haloperidol (to) 15mg DD
60 P-AP/A risperidone (tf) 4mg DD,
clozapine (to) 6.25mg DD
61 R-AP/A clozapine (to) 200mg DD
62 R-AP/A olanzapine (tf) 10mg DD
63 R-AP/T fluphenazine decanoate (im) 25mg 4W
DD, daily; AD, on alternate days; 2W/3W/4W, every 2/3/4 weeks; to, tablet; tc, tablet,
coated; tf, tablet, film coated; te, tablet, film coated, extended release; td, tablet, orally
disintegrating; pl, pill; cp, capsule; im, injection, solution, intramuscular; ie, injection,
suspension, extended release, intramuscular; so, solution, oral.
the sEMG measured with some of the loads, so those records
were excluded from the study (the number of patients, group,
loads: 1 P-AP/T 3 kg, 1 P-AP/A 0 kg, 1 P-DN 2,3 kg, 2 R-AP/TA
3 kg). The other 80 measurements were used completely.
A visual check of the sEMG spectra revealed that the spectra
of some records had sharp peaks at frequencies multiple of 50
Hz, so we applied Fourier interpolation suggested by Mewett
et al. (2004) to all the records. The amplitudes at frequencies
multiple of 50 Hz in the range 50–400 Hz were replaced
by linearly interpolated values calculated from two adjacent
points (±1 Hz), and the phases were kept the same. Then the
records were low-pass filtered with the 14th order elliptic filter
designed with Matlab design function (passband frequency
420 Hz, stopband frequency 500 Hz, passband ripple 2· 10−6
dB, stopband attenuation 80 dB, passband exact match). Then
the signals were detrended with smoothness priors method
introduced by Tarvainen et al. (2002) to remove the movement
artifacts those might remain after high-pass filtering by the
device. Smoothness priors detrending method can be viewed as
a time-varying FIR high-pass filter, which causes less attenuation
in the beginning and the end of a signal. This method can be
used for trend estimation or removal of the trend by subtracting
it from the signal. The only detrending parameter λ affects the
trend smoothness. Larger λ values correspond to more smooth
trends and lower cutoff frequencies. We used λdetr = 10
5, which
corresponds to attenuation of –40 dB at 10 Hz in the middle of a
signal.
We calculatedmean andmedian frequencies of amplitude and
power FFT spectra (MNFA, MDFA, MNFP, MDFP). The signals
were windowed with Hanning window before the calculations to
eliminate the spectrum distortion caused by discontinuities at the
beginning and the end of a signal.
A phase space embedding procedure was performed for
the further parameters calculations. Signal values {x1, x2, ..., xn}
were replaced by vectorsXi inm-dimensional space (Equation 1),
with L being the time lag.
Xi = (xi, xi+L, xi+2L, ..., xi+(m−1)L) (1)
If m and L values are correct, then Xi values make up a smooth
trajectory in Rm space, which corresponds to the dynamics of the
examined system. Mathematical justification of this procedure is
the embedding theorem by Takens (1981) and Mañé (1981). L
was chosen with the help of mutual information as recommended
by Fraser and Swinney (1986), and Celucci et al. (2003). For each
signal we calculated mutual information I of the signal and the
same signal shifted backwards in time on τ sampling periods with
τ varying from 1 to 100. The dependence I(τ ) was calculated
using the program of Weeks (1997). Since I(τ ) dependencies
were noisy, they were replaced by their trends obtained using
smoothness priors method with λtr = 9.1. The first minimum
T of an I(τ ) trend was used as a separate sEMG parameter, and
the optimal time lag L was chosen as mean T (L = 45). The
smoothness priors parameter λtr = 9.1was chosen from themost
wide range where λ did not affect T of any record. Namely, we
determined the dependence T(λ) for each record and obtained
that λ > 15.531 gave strictly decreasing trends for some records,
and 8.985 ≤ λ ≤ 9.144 was the most wide range that gave stable
T for all the records. The embedding dimension m was chosen
with the help of false nearest neighbors (FNN) method as advised
by Celucci et al. (2003) and Kennel et al. (1992). We calculated
the number of FNNs for each record withm varying from 1 to 15
and normalized the numbers by the number of FNNs for m = 1
multiplied by 100%. Minimum m that gave not more that 1% of
FNNs for any record was chosen as the embedding dimension
(m = 5).
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Then approximate entropy (ApEn, Pincus, 1991) and
sample entropy (SampEn, Richman and Moorman, 2000) were
calculated using Euclidian interpoint distances and the tolerance
distances rApEn = 0.65 and rSampEn = 0.8756. The records were
normalized to unit standard deviation. rApEn and rSampEn were
fitted to maximize Shannon entropies of the ApEn and SampEn
distributions correspondingly. Each of the two distributions
consisted of 334 bins ranging from ApEnmin to ApEnmax and
from SampEnmin to SampEnmax correspondingly.
Further analysis was performed by means of recurrence plots
described by Marwan et al. (2007). Recurrence plot Rec is a
matrix of size N×N, where N is the number of trajectory points.
Matrix element at the crossing of a column and a row is equal to
one (black point), if the points corresponding to the column and
the row are not further apart from each other than ε, and is equal
to zero (white point) otherwise as in Equation (2), where i, j =
1...N,2(•) is the Heaviside function, ‖X‖ is Euclidean norm.
Reci,j = 2(ε − ‖Xi − Xj‖) (2)
Recurrence plot makes it possible to analyze how often and
for how long time a system returns to its previous states. As
consecutive trajectory points are almost always close to each
other, their proximity is not informative, so pairs of points
with index difference less than W should not be considered.
If W > 0, recurrence plot includes white strip along main
diagonal, with horizontal width 1 + 2(W − 1) points. Then
recurrence quantification analysis (RQA, Marwan et al., 2007)
of the recurrence plots was performed. We calculated RR (share
of black points of Rec), determinism DET (share of black points
that form diagonal lines), laminarity LAM (share of black points
that form vertical lines), RATIO = DET/RR, average diagonal
line length L, average vertical line length (trapping time) TT,
maximum diagonal line length Lmax, maximum vertical line
length Vmax, divergence DIV = 1/Lmax, Shannon entropy
of diagonal lines lengths probability distribution ENTR, and
TREND. Key parameters lmin and vmin are required to calculate
DET, LAM, L, TT, and ENTR. We fitted the key parameters ε,
W, and lmin to maximize sensitivity of DET to the load, namely
we maximized sum of absolute values of Kendall’s correlation
coefficients of dependencies of DET on load among all subjects
but the one with 2 and 3 kg records excluded (W = 6, lmin = 3,
ε = 0.09 · E‖Xi −Xj‖, i 6= j, where E means mean, and the mean
is calculated using all the points pairs, including those with index
difference less than W). vmin was fitted to maximize similar sum
of correlation coefficients for LAM given ε and W chosen with
the help of DET (vmin = 3). Parameter N˜ required for measure
TREND was chosen as N − 10 (N˜ = 19811).
The order of statistical analysis is stated in Table 3.
Kolmogorov-Smirnov test showed that the distribution of the
sEMG parameters was not normal in almost all of the subjects
groups, so we chose Kruskal–Wallis andMann–Whitney tests for
comparisons of the sEMG parameters between the groups. First
we compared sEMG parameters between the eight indivisible
subgroups P-AP/T, P-AP/A, P-AP/TA, R-AP/T, R-AP/A, R-
AP/TA, P-NAP/DN, and Con using Kruskal–Wallis test (H0 in
Table 3). The comparison was made for each sEMG parameter
and each load separately (18 · 4 tests). Then hypotheses H1–
H10 from Table 3 were tested using Mann-Whithey test only for
the parameters and loads those were significantly different in the
eight indivisible subgroups (p < 0.05 in H0 test). Bonferroni
correction was applied to the significance level in the H1–H10
tests, namely only hypotheses with p < 0.05/10 were rejected.
Clinical scales SAS and AIMS were compared between the All-
AP and All-DN groups (H11–H12 in Table 3). We calculated
Kendall’s τ and Spearman’s ρ correlation coefficients between the
clinical scales and the sEMG parameters for each load separately.
Correlation between the sEMG parameters and PANSS and PSS
was calculated for the All-All group (H13–H14 in Table 3).
Correlation between the sEMG parameters and SAS and AIMS
was calculated for the All-AP group (H15–H16 in Table 3).
Then the dimensionality of the data was reduced by means of
principal component analysis (PCA, Jolliffe, 2002). The essence
of PCA is to represent a set of feature vectors as a weighed sum of
basis vectors, with weights being the principal components. We
formed feature vectors zT (Equation 3) from sEMG parameters
those were statistically significantly different in any of H1–H10
tests at 1 kg load. Each parameter was normalized to mean and
standard deviation of its values.
zT = [SampEn DET L TT ENTR] (3)
Then we obtained an orthonormal set of basis vectors, which
represent directions ofmaximum variance in a space of the sEMG
parameters included in zT . The basis vectors were solved using
experimental correlation matrix obtained from the parameters
for all subjects. We formed matrix Z from rows zTi of the sEMG
parameters, each corresponding to the i-th subject, and calculated
correlation matrix R as in Equation (4), where Ns is the number
of subjects.
R =
1
Ns
ZTZ (4)
Then we obtained eigenvectors and eigenvalues of R. The
eigenvectors were used as basis vectors. We sorted the basis
vectors in decreasing order of their corresponding eigenvalues
and formed matrix H using as columns the first two basis
vectors, the eigenvalues of which constituted more than 95% of
the total sum of the eigenvalues. Then the basis vectors were
used to calculate principal components θˆ for all subjects as in
Equation (5).
θˆ = ZH (5)
Columns and rows of the matrix θˆ correspond to principal
components and subjects respectively. Thus, the two columns
(principal components) of θˆ consist of projections of the sEMG
parameters on two directions of the greatest variance.
3. Results
sEMG parameters were statistically significantly different (p <
0.05) between the eight indivisible groups for nine combinations
of loads and parameters. SeeTable 4 for the loads and parameters.
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TABLE 3 | Null hypotheses and the groups of subjects used in corresponding statistical tests.
No. Hypothesis Subjects groups
H0 sEMG parameters have the same distributions in the groups P-AP/T, P-AP/A, P-AP/TA, R-AP/T, R-AP/A,
R-AP/TA, P-NAP/DN, Con.
–
H1 Psychosis state does not influence sEMG parameters. Con and P-NAP/DN
H2 Provided psychosis state, taking of typical AP at the moment of study does not influence sEMG parameters. P-AP/T and P-NAP/DN
H3 Provided psychosis state, taking of atypical AP at the moment of study does not influence sEMG parameters. P-AP/A and P-NAP/DN
H4 Provided psychosis state, taking of both typical and atypical AP at the moment of study does not influence sEMG
parameters.
P-AP/TA and P-NAP/DN
H5 Provided psychosis state, taking of typical AP at the moment of study influences sEMG parameters in the same
way as taking of atypical AP at the moment of study.
P-AP/T and P-AP/A
H6 Provided psychosis state, taking of typical AP at the moment of study influences sEMG parameters in the same
way as taking of both typical and atypical AP at the moment of study.
P-AP/T and P-AP/TA
H7 Provided psychosis state, taking of atypical AP at the moment of study influences sEMG parameters in the same
way as taking of both typical and atypical AP at the moment of study.
P-AP/A and P-AP/TA
H8 Provided remission state, taking of typical AP at the moment of study influences sEMG parameters in the same
way as taking of atypical AP at the moment of study.
R-AP/T and R-AP/A
H9 Provided remission state, taking of typical AP at the moment of study influences sEMG parameters in the same
way as taking of both typical and atypical AP at the moment of study.
R-AP/T and R-AP/TA
H10 Provided remission state, taking of atypical AP at the moment of study influences sEMG parameters in the same
way as taking of both typical and atypical AP at the moment of study.
R-AP/A and R-AP/TA
H11 Taking of antipsychotics at the moment of study does not influence SAS All-AP and All-DN
H12 Taking of antipsychotics at the moment of study does not influence AIMS All-AP and All-DN
H13 sEMG parameters do not correlate to PANSS All-All
H14 sEMG parameters do not correlate to PSS All-All
H15 Provided taking of any antipsychotics at the moment of study, sEMG parameters do not correlate to SAS All-AP
H16 Provided taking of any antipsychotics at the moment of study, sEMG parameters do not correlate to AIMS All-AP
Rejected null hypotheses are marked with boldface.
TABLE 4 | p-values from Mann–Whitney test of hypotheses H1–H10.
Parameter Load (kg) H1 H2 H3 H4 H5 H6 H7 H8 H9 H10
Lmax 0 0.767 0.605 0.65 1.04·10−2 0.849 2.46·10−2 4.68·10−3 0.833 0.267 0.7
DIV 0 0.767 0.605 0.65 1.04·10−2 0.849 2.46·10−2 4.68·10−3 0.833 0.267 0.7
SampEn 1 0.325 0.544 0.104 3.86·10−3 0.767 7.49·10−3 3.78·10−3 0.833 1 1
DET 1 0.793 0.669 0.451 8.62·10−3 0.375 2.41·10−3 9.91·10−4 1 0.833 1
L 1 0.555 0.77 0.19 4.75·10−3 0.291 1.79·10−3 1.97·10−3 0.667 0.667 1
TT 1 0.599 1 0.383 7.1·10−3 0.422 2.8·10−3 6.19·10−3 0.383 0.383 0.7
ENTR 1 0.646 0.911 0.302 4.75·10−3 0.278 1.53·10−3 2.57·10−3 0.667 1 1
L 2 0.218 0.981 0.882 1.24·10−2 0.944 2.06·10−2 6.98·10−3 0.667 0.833 1
Vmax 2 0.157 0.904 0.458 1.96·10−2 0.877 2.17·10−2 2.34·10−2 0.283 0.183 0.5
Only sEMG parameters and loads combinations those were statistically significantly different in comparison of the eight indivisible patients groups using Kruskal–Wallis test (H0 in
Table 3) are included.
Frontiers in Physiology | www.frontiersin.org 6 July 2015 | Volume 6 | Article 197
Meigal et al. Nonlinear sEMG parameters in schizophrenia
The inter-group comparisons showed that sEMG parameters
values for the P-AP/TA group were statistically significantly
different from those for the P-AP/T, P-AP/A, and P-DN groups.
The P-AP/T group had significantly lower values of DET, L,
TT, and ENTR at 1 kg than the P-AP/TA group. The P-AP/A
group had significantly lower values of Lmax at 0 kg, DET,
L, and ENTR at 1 kg and significantly higher values of DIV
at 0 kg and SampEn at 1 kg than the P-AP/TA group. The
P-DN group had significantly lower values of L and ENTR
at 1 kg and significantly higher values of SampEn at 1 kg
than the P-AP/TA group. See Table 5 for median values of
the sEMG parameters. There were no statistically significant
differences in any other inter-group comparisons of sEMG
parameters. See Table 4 for the p-values from Mann–Whitney
test of hypotheses H1–H10. Only hypotheses H4, H6, and
H7 (comparisons with the P-AP/TA group) produced small
p-values.
The All-AP group had statistically significantly higher values
of SAS and AIMS than the All-DN group. See Table 6 for the
median values of SAS and AIMS. No correlations were detected
between the sEMG parameters and the clinical scales in the
All-All and All-AP groups.
The data points composed a two-tailed curved distribution
on the plot from PCA (Figure 2), which has first and second
principal components as its x- and y-axes correspondingly. The
All-AP/TA group tends to scatter around the right tail of the
distribution. The P-DN group forms a tight cluster near the
origin. Graphic changes of myoelectical signal are visible when
moving from one tail of the distribution to another. See the
graphs of sEMG of subjects located on various areas of the
PC-plot on Figure 3.
TABLE 5 | Comparisons of median values of sEMG parameters between
P-AP/TA and other groups.
Parameter Load (kg) P-AP/TA P-AP/A P-AP/T DN Con
Lmax (ms) 0 25.5 10.8* 11 9.8 7.6
DIV (Hz) 0 39.2 92.4* 91.2 102.6 131.6
SampEn 1 0.818 0.869* 0.877 0.894* 0.877
DET 1 0.962 0.899* 0.849* 0.881 0.894
L (µs) 1 462 346* 309* 291* 325
TT (µs) 1 321 254 251* 252 253
ENTR (bit) 1 4.01 3.33* 3.12* 3.05* 3.30
*p < 0.005 significant differences with the P-AP/TA group after Bonferroni correction.
p < 0.05 for all comparisons with the P-AP/TA group shown in this table.
TABLE 6 | Comparison of median values of SAS and AIMS.
Scale All-DN All-AP
SAS 0 3*
AIMS 0 1**
*p = 9.05 · 10−5; **p = 0.0166 for the comparisons between the All-AP group and the
All-DN group.
4. Discussion
We hypothesized that sEMG parameters, especially the nonlinear
ones, might correlate with the clinical symptoms and medication
in SZ patients. We hoped to set a kind of “muscle channel”
of information on SZ from the central nervous system via
sEMG parameters. Earlier, we found that SZ patients in
remission phase were undistinguishable from the control group
by sEMG parameters, while those in psychosis phase had greater
values of the nonlinear sEMG parameters, e.g., determinism
(Miroshnichenko et al., 2014). Increased determinism of
sEMG may evidence elevated degree of motor units activity
synchronization (Fattorini et al., 2005). In turn, this may
be indicative of the neuroleptic-induced parkinsonism (NIP),
FIGURE 2 | Feature vectors of the subjects in a space of principal
components. Bottom plot is the gray rectangle on the upper plot. Numbers
near the outliers are ages of the patients.
Frontiers in Physiology | www.frontiersin.org 7 July 2015 | Volume 6 | Article 197
Meigal et al. Nonlinear sEMG parameters in schizophrenia
FIGURE 3 | sEMG of some subjects measured with 1 kg load on palm. The locations of the subjects on the PC plot (upper part of Figure 2) are described in the
graphs titles.
which is very common in SZ patients treated by antipsychotics
(Friedman, 2014). Therefore, we expected presence of NIP in the
All-AP group of patients.
In the present study, sEMG parameters in the controls
were not different from those of the drug-naïve SZ patients
who had never taken antipsychotics (P-DN, hypothesis H1).
Thus, in contrary to this hypothesis (H1), “intact” SZ patients
were electromyographically indistinguishable from the healthy
controls. Thus, the SZ-related neurotransmitter disorders in the
CNS do not affect the spinal cord. Absence of correlation between
PANSS and sEMG parameters supports that statement.
However, we found that the SZ patients who were
administered both typical and atypical antipsychotics (P-
AP/TA) presented statistically significant difference of the
sEMG parameters from the groups of drug-naïve patients and
those receiving exclusively typical or atypical antipsychotics
(hypotheses H4, H6, and H7 were rejected). In average, the
nonlinear sEMG parameters were almost twice lower or higher
for the P-AP/AT group of SZ patients in comparison to the
other medication groups. It is known that atypical AP, unlike
the typical ones, usually produce less NIP (Gurevich et al., 2012;
Knol et al., 2012; Marras et al., 2012). We probably evidenced
a kind of synergistic effect of these two classes of AP, i.e. our
result may mean the greater blockade of the dopaminergic
receptors in the CNS in case of combined typical/atypical
AP therapy. It is likely that increased synchronization of MU
activity may account for elevated regularity of sEMG in the
P-AP/TA patients (Fattorini et al., 2005). However, an alternative
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explanation may be figured out. It is known that in SZ patients
the denervation/reinnervation process takes place (Crayton
et al., 1977). Thus, a large (giant) motor unit might have been
firing constantly in the proximity of the recording electrode due
to sprouting effect (Seburn et al., 1996).
In a whole, the sEMG data proved to be indicative of the
elevated regularity of the myoelectrical signal in the group of
SZ patients who were administered both typical and atypical
AP. This would allow discriminating groups of SZ patients
those differ by their anti-SZ medication using sEMG parameters.
An example of sEMG with appreciably elevated regularity can
be seen on the topmost graph of Figure 3. The difference of
SAS and AIMS between the group of patients who were taking
any antipsychotics at the moment of study and the group of
drug-naïve patients (hypotheses H11 and H12 were rejected)
supports the hypothesis about presence of NIP in the All-AP
group.
It can be seen on the PCA plot that most of outliers in the right
tail of the data distribution are aged SZ patients. This prompts
that the age, in addition to the disease per se, may contribute
to the sEMG characteristics in SZ, even though the number
of the points is not enough for any reliable conclusions. It is
known that the motor system undergoes substantial age-related
remodeling (Jang and van Remmen, 2011). sEMG parameters
are also modified throughout the life (Boccia et al., 2014). This
suggests further investigation of sEMG in aged SZ patients.
In the present study, the best discrimination power between
groups was the characteristic of smaller loading of arms (no
loading and 1 kg). That might be attributable to a known fact
that, for example, in the Parkinson’s disease patients sEMG
data becomes more “normal” under bigger loads. This probably
evidenced emergency of a “normal” physiological muscle tone
evoked by an external load (Meigal et al., 2009). Thus, smaller
loads seem to be more informative in sEMG-based diagnostics.
In conclusion, the nonlinear sEMG parameters might be
helpful in early detection of neuroleptic-induced parkinsonism
during treatment with typical and atypical antipsychotics.
Further studies are needed to elucidate the possible role of the
disease duration, age and sex in forming sEMG characteristics
in SZ.
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